Associated Principle Investigator | Chang Gung University | Taiwan
Dr. Chungyin Lin is a distinguished researcher whose work spans neuroscience, molecular biochemistry, and advanced diagnostic technologies, with a strong record of scientific influence demonstrated by 43 peer-reviewed publications and more than 1,817 citations. His research portfolio encompasses the molecular mechanisms underlying neurodegenerative disorders, with notable investigations into tau-related neuroinflammation, mitochondrial dysfunction, dysregulation of choline metabolism, and the therapeutic potential of bioactive compounds such as citicoline and kynurenic acid. Dr. Lin has also contributed significantly to translational diagnostic science through the development of paper-based molecularly imprinted sensing platforms designed for sensitive and accessible biomarker detection, reflecting a broader commitment to bridging biological insights with practical clinical tools. His publications in widely recognized journals highlight a sustained focus on disorders such as Huntington’s disease and Parkinson’s disease, where his findings support ongoing advancements in early diagnosis, therapeutic targeting, and neuroprotective intervention strategies. Dr. Lin’s work is further strengthened by extensive interdisciplinary collaboration, having co-authored studies with over 130 researchers from diverse scientific domains, including clinicians, pharmacologists, materials scientists, and biomedical engineers. These collaborations have accelerated progress in understanding disease-related biochemical pathways, developing innovative detection methods, and proposing new therapeutic hypotheses, thereby enhancing the societal and scientific impact of his research. With an h-index of 21, Dr. Lin continues to contribute meaningfully to global biomedical research through rigorous experimentation, integrative methodology, and a vision oriented toward improving human health through scientific innovation.
Featured Publications
Lin, T.-H., Tseng, P.-H., Chen, I.-C., & Chen, C.-M. (2025). The potential of mulberry (Morus alba L.) leaf extract against pro-aggregant Tau-mediated inflammation and mitochondrial dysfunction.
Lin, T.-C., Lin, C. Y., Hwang, Y.-T., & Tai, D.-F. (2025). Paper-based molecularly imprinted film designs for sensing human serum albumin.
Chang, K.-H., Cheng, M.-L., Tang, H.-Y., et al., & Chen, C.-M. (2024). Dysregulation of choline metabolism and therapeutic potential of citicoline in Huntington’s disease.
Chen, C.-M., Huang, C.-Y., Lai, C.-H., et al., & Lin, C. Y. (2024). Neuroprotection effects of kynurenic acid-loaded micelles for the Parkinson’s disease models.
Yang, P.-N., Chen, W.-L., Lee, J.-W., et al., & Lee-Chen, G.-J. (2023). Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against α-synuclein toxicity.
Dr. Chungyin Lin’s research advances global understanding of neurodegeneration while driving innovative diagnostic and therapeutic strategies that address critical unmet needs in neurological health. His interdisciplinary work bridges molecular science, technology, and clinical application, contributing meaningful solutions that enhance healthcare outcomes and societal well-being.